Company Number: 13515325

Analysis Date: 2025-07-20 16:26 UTC

1. Credit Opinion: DECLINE
   DR CHRISTINA LTD shows a concerning financial position with persistent negative net current assets and shareholders’ funds of -£8,307 as of 31 July 2024, which has remained unchanged for three years. The company’s liabilities far exceed its current assets, indicating an inability to meet short-term obligations without external financing or capital injection. Given the micro-entity size and absence of growth or any apparent operational scale (no employees currently), the risk of default is high. The director is the sole owner and controller, which concentrates risk and limits external governance. Therefore, credit approval is not recommended at this time.

2. Financial Strength:
   The balance sheet reveals total current assets of £943 against current liabilities of £8,980, resulting in a negative working capital of £8,037. The company’s net assets and shareholder funds are negative by the same amount, reflecting an overall deficit and weak capital structure. No fixed assets or other long-term assets are reported, which limits collateral availability. The company has remained in this financially distressed state consistently since incorporation in 2021, showing neither asset growth nor liability reduction.

3. Cash Flow Assessment:
   With current liabilities nearly ten times current assets and no employees currently retained, liquidity is severely constrained. The financial statements do not detail cash flow or operating income, but the negative net working capital implies the company cannot cover its immediate debts from liquid resources. This raises serious concerns about ongoing operational viability and ability to service any credit facility without substantial external support.

4. Monitoring Points:

• Monitor changes in current liabilities and current assets closely for any improvement in liquidity.
• Watch for new filings indicating operational activity or changes in business scale.
• Track director’s financial commitments or external funding injections that might improve working capital.
• Review any upcoming changes in company status or credit events (e.g., insolvency proceedings).